Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
Home > Vol 40, No 5 (2022) > Rakpraisuthepsiri

Efficacy of a Modified Sepsis System on the Mortality Rate of Septic Shock Patients in the Emergency Department of Siriraj Hospital

Natvadee Rakpraisuthepsiri, Usapan Surabenjawong, Chok Limsuwat, Ploylarp Lertvipapath

Abstract

Objective: To compare the 28-day mortality rate between pre- and post-implementation of a modified sepsis fast-track system.
Material and Methods: A cross-sectional cohort study was conducted at the Emergency Room (ER) of Siriraj Hospital, Bangkok. All patients who were diagnosed with septic shock and who received antimicrobial treatment at admission in the ER were included.
Results: In total, 420 patients were included in the study, split into 210 patients in the pre-protocol group and 210 patients in the post-protocol group. Comparing between pre- and post-modified sepsis fast-track system implementation, the patients who received antimicrobials within 1 hour numbered 140 (66.7%) and 175 (83.3%), respectively (OR 2.5, 95% CI 1.57–3.97, p-value<0.001). The 28-day mortality rates of the pre- and post-protocol groups were 44.8% vs. 34.8% (p-value=0.036). According to the multivariate analysis, the factors that were significantly related to 28-day mortality in patients with septic shock were age greater than 75 years, diabetes mellitus, and initial SOFA score >9.
Conclusion: Implementation of a modified sepsis program improved the time to first antimicrobial administration and decreased the 28-day mortality for patients with septic shock in the ER.

 Keywords

antimicrobials; sepsis program modification; septic shock

 Full Text:

PDF

References

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801-10.

Rudd KE, Johnson SC AK, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet 2020;395:200-11.

Angkasekwinai N, Rattanaumpawan P, Thamlikitkul V. Epidemiology of sepsis in Siriraj Hospital 2007. J Med Assoc Thai 2009;92:S68-78.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy collaborative group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.

Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014;42:1749-55.

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47:1181–247.

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.

Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237-48.

Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med 2018;46:997-1000.

Gaieski DF, Pines JM, Band RA, Mikkelsen ME, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goaldirected therapy was initiated in the emergency department. Crit Care Med 2010;38:1-9.

DOI: http://dx.doi.org/10.31584/jhsmr.2022865

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2024

Journal Metrics


2020
Acceptance rate: 52%
2021
Acceptance rate: 27.8%
2022 (March)
Acceptance rate: 15.6%
2023 (June)
Acceptance rate: 23.6%
2024 (June)
Acceptance rate: 19%


Submission to final decision
74 days

Acceptance to publication
40 days

0.6
2024CiteScore
 
 
31st percentile
Powered by Scopus



 

 

SCImago Journal & Country Rank

About The Authors

Natvadee Rakpraisuthepsiri
Outpatient Pharmacy Division, Department of Pharmacy, Faculty of Medicine Siriraj Hospital, Bangkok Noi, Bangkok 10700,
Thailand

Usapan Surabenjawong
Department of Emergency Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok 10700,
Thailand

Chok Limsuwat
Department of Emergency Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok 10700,
Thailand

Ploylarp Lertvipapath
Adverse Drug Reaction Unit, Division of Academic Affairs, Department of Pharmacy, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok 10700,
Thailand

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Supported by

 

JHSMR now Indexed in



Scopus logo.svg






Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand Vietnam anxiety children computed tomography depression diabetes diabetes mellitus elderly knowledge mental health mortality prevalence quality of life reliability risk factors stroke treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Open Journal Systems